Benzoxadiazole derivatives as TAL effector antagonists for rice bacterial blight control

Overview

This research proposes the validation of benzoxadiazole derivatives as small-molecule antagonists targeting TAL effectors (specifically PthXo1) of Xanthomonas oryzae, the causative agent of bacterial blight in rice. By blocking the interaction between TAL effectors and rice DNA, these compounds aim to prevent bacterial blight infection at the molecular level. The proposal is based on an in silico screening campaign against a synthetic compound database of 1.8 million compounds, followed by de novo design optimization to improve binding affinity. A curated library of nine benzoxadiazole derivatives has been generated and has shown promising computational results, positioning this as a potential agrochemical innovation for crop disease management.

Technical specifications

Research approach:

• Target identification: TAL effector PthXo1 selected as the protein target, based on its role as a key virulence factor enabling Xanthomonas oryzae to hijack rice gene expression
• In silico screening: Large-scale virtual screening against a 1.8 million compound synthetic database identified ZINC15767804 as the top-hit lead compound
• De novo design: Using the interaction profile of the top hit as a template, side chain fragments were modified to enhance binding affinity with TAL effectors
• Derivative library: Nine benzoxadiazole-based derivatives designed and computationally evaluated with confident binding results
• Mechanism of action: Compounds are designed to bind PthXo1 and prevent its interaction with host rice DNA, thereby disrupting the pathogen's ability to manipulate the plant's transcriptional machinery

Key advantages:

• Small-molecule approach enables potential formulation as a field-applicable agrochemical
• Targets a conserved virulence mechanism rather than bacterial viability, potentially reducing resistance development
• Computational pipeline allows rapid optimization and expansion of the compound library

Technology readiness level

This research is currently at an early computational stage (TRL 2–3). The benzoxadiazole derivatives have been designed and evaluated through in silico methods, including molecular docking and interaction profiling. The next phase requires experimental validation through in vitro binding assays, followed by in vivo efficacy testing in rice plants challenged with Xanthomonas oryzae. The research team at R.V. College of Engineering, Bengaluru, is seeking collaboration and funding to advance these computationally validated candidates toward laboratory and field validation.